Dual-Pathway Fusion of EHRs and Knowledge Graphs for Predicting Unseen Drug-Drug Interactions

• URL: http://arxiv.org/abs/2511.06662v1
• Date: Mon, 10 Nov 2025 03:18:16 GMT
• Title: Dual-Pathway Fusion of EHRs and Knowledge Graphs for Predicting Unseen Drug-Drug Interactions
• Authors: Franklin Lee, Tengfei Ma,
• Abstract summary: Drug-drug interactions (DDIs) remain a major source of preventable harm.<n>We introduce, to our knowledge, the first system that conditions KG relation scoring on patient-level EHR context.<n>A fusion "Teacher" learns mechanism-specific relations for drug pairs represented in both sources.<n>A distilled "Student" generalizes to new or rarely used drugs without KG access at inference.
• Score: 5.481037938702276
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Drug-drug interactions (DDIs) remain a major source of preventable harm, and many clinically important mechanisms are still unknown. Existing models either rely on pharmacologic knowledge graphs (KGs), which fail on unseen drugs, or on electronic health records (EHRs), which are noisy, temporal, and site-dependent. We introduce, to our knowledge, the first system that conditions KG relation scoring on patient-level EHR context and distills that reasoning into an EHR-only model for zero-shot inference. A fusion "Teacher" learns mechanism-specific relations for drug pairs represented in both sources, while a distilled "Student" generalizes to new or rarely used drugs without KG access at inference. Both operate under a shared ontology (set) of pharmacologic mechanisms (drug relations) to produce interpretable, auditable alerts rather than opaque risk scores. Trained on a multi-institution EHR corpus paired with a curated DrugBank DDI graph, and evaluated using a clinically aligned, decision-focused protocol with leakage-safe negatives that avoid artificially easy pairs, the system maintains precision across multi-institutuion test data, produces mechanism-specific, clinically consistent predictions, reduces false alerts (higher precision) at comparable overall detection performance (F1), and misses fewer true interactions compared to prior methods. Case studies further show zero-shot identification of clinically recognized CYP-mediated and pharmacodynamic mechanisms for drugs absent from the KG, supporting real-world use in clinical decision support and pharmacovigilance.

Related papers

• A Hybrid Computational Intelligence Framework with Metaheuristic Optimization for Drug-Drug Interaction Prediction [0.8602553195689512]
  Drug-drug interactions (DDIs) are a leading cause of preventable adverse events, often complicating treatment and increasing healthcare costs.<n>We propose an interpretable and efficient framework that blends modern machine learning with domain knowledge to improve DDI prediction.<n>Our approach combines two complementary embeddings - Mol2Vec, which captures fragment-level structural patterns, and SMILES-BERT, which learns contextual chemical features.
  arXiv  Detail & Related papers  (2025-10-08T09:55:18Z)
• KITE-DDI: A Knowledge graph Integrated Transformer Model for accurately predicting Drug-Drug Interaction Events from Drug SMILES and Biomedical Knowledge Graph [0.11049608786515838]
  Drug-Drug Interactions (DDI) can cause significant bodily injury and even death.<n>Most contemporary research for predicting DDI events relies on either information from Biomedical Knowledge graphs (KG) or drug SMILES.<n>In this study, we propose a KG-integrated Transformer architecture to generate an end-to-end fully automated Machine Learning pipeline.
  arXiv  Detail & Related papers  (2024-12-08T00:49:57Z)
• HELIOT: LLM-Based CDSS for Adverse Drug Reaction Management [3.2627279988912194]
  Heliot is an innovative Clinical Decision Support System (CDSS) for adverse drug reaction management.<n>It processes free-text clinical information using Large Language Models (LLMs) integrated with a comprehensive pharmaceutical data repository.<n>Heliot learns from past patient-specific medication tolerances to reduce false alerts, enabling more nuanced and contextual adverse drug event warnings.
  arXiv  Detail & Related papers  (2024-09-24T18:55:10Z)
• Leave No Patient Behind: Enhancing Medication Recommendation for Rare Disease Patients [47.68396964741116]
  We propose a novel model called Robust and Accurate REcommendations for Medication (RAREMed) to enhance accuracy for rare diseases. It employs a transformer encoder with a unified input sequence approach to capture complex relationships among disease and procedure codes. It provides accurate drug sets for both rare and common disease patients, thereby mitigating unfairness in medication recommendation systems.
  arXiv  Detail & Related papers  (2024-03-26T14:36:22Z)
• DDIPrompt: Drug-Drug Interaction Event Prediction based on Graph Prompt Learning [15.69547371747469]
  DDIPrompt is an innovative solution inspired by the recent advancements in graph prompt learning. Our framework aims to address these issues by leveraging intrinsic the knowledge from pre-trained models. Extensive experiments on two benchmark datasets demonstrate DDIPrompt's SOTA performance.
  arXiv  Detail & Related papers  (2024-02-18T06:22:01Z)
• DTIAM: A unified framework for predicting drug-target interactions, binding affinities and activation/inhibition mechanisms [9.671391525450716]
  We introduce a unified framework called DTIAM, which aims to predict interactions, binding affinities, and activation/inhibition mechanisms between drugs and targets. DTIAM learns drug and target representations from large amounts of label-free data through self-supervised pre-training. It achieves substantial performance improvement over other state-of-the-art methods in all tasks, particularly in the cold start scenario.
  arXiv  Detail & Related papers  (2023-12-23T13:27:41Z)
• Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
  We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction. BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner. It maintains consistent and robust semantics by smoothing relations around the target interaction.
  arXiv  Detail & Related papers  (2023-12-09T07:08:00Z)
• KGML-xDTD: A Knowledge Graph-based Machine Learning Framework for Drug Treatment Prediction and Mechanism Description [11.64859287146094]
  We propose KGML-xDTD: a Knowledge Graph-based Machine Learning framework for explainably predicting Drugs Treating Diseases. We leverage knowledge-and-publication based information to extract biologically meaningful "demonstration paths" as the intermediate guidance in the Graph-based Reinforcement Learning process.
  arXiv  Detail & Related papers  (2022-11-30T17:05:22Z)
• Knowledge-Driven New Drug Recommendation [88.35607943144261]
  We develop a drug-dependent multi-phenotype few-shot learner to bridge the gap between existing and new drugs. EDGE eliminates the false-negative supervision signal using an external drug-disease knowledge base. Results show that EDGE achieves 7.3% improvement on the ROC-AUC score over the best baseline.
  arXiv  Detail & Related papers  (2022-10-11T16:07:52Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Data [56.53715632642495]
  Clinical trials face uncertain outcomes due to issues with efficacy, safety, or problems with patient recruitment. In this paper, we propose Hierarchical INteraction Network (HINT) for more general, clinical trial outcome predictions.
  arXiv  Detail & Related papers  (2021-02-08T15:09:07Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.